A few weeks ago the U.S. National Toxicology Program (NTP) released the results of the largest study ever conducted on bisphenol A (BPA). The CLARITY Core study was conducted by senior scientists with the U.S. Food and Drug Administration (FDA) in their own laboratory in Arkansas known as the National Center for Toxicological Research (NCTR).
The Dr. Joe Show is a radio show broadcast on CJAD 800 AM in Montreal, Quebec, Canada. Host Joseph Schwarz, Ph.D., director of McGill University’s Office for Science & Society, focuses on “debunking myths and answering questions about the science of everyday life.” In this segment, he and Steve Hentges, Ph.D., discuss the history and uses of BPA, the data from the recent CLARITY Core Study, and the importance of looking at all the parts of a study, especially exposure.
Bisphenol A, more commonly known as BPA, has often been considered a harmful substance found in plastics and resins by the general public. The Food and Drug Administration released a statement about its ongoing research about the harmful effects of BPA.
The Food and Drug Administration (FDA) has released new findings concerning the fears of a certain chemical used in our food and drink containers. Steven G. Hentges, Ph.D. Polycarbonate/BPA Global Group of the American Chemistry Council offers details on the announcement.
On February 23, 2018, the Food and Drug Administration (FDA) released a statement by Deputy Commissioner for Foods and Veterinary Medicine Stephen Ostroff, M.D., regarding a draft report issued by the National Toxicology Program (NTP) on the compound bisphenol A, more commonly referred to as BPA. The report concluded that BPA, the compound used to produce strong plastic products and epoxy resins, is safe.
If you’ve ever heard of the chemical bisphenol A (BPA), and who hasn’t, you probably have the distinct impression that it’s highly toxic. After a steady drumbeat of more than 15 years suggesting that BPA is linked to virtually every health effect known to man, how could you think any differently?
The National Toxicology Program (NTP) released a draft report Feb. 23 from one of two distinct but complimentary arms of a study called the Consortium Linking Academic and Regulatory Insights on BPA Toxicity, or CLARITY-BPA. This research initiative is studying the full range of potential health effects in rats from exposure to bisphenol A (BPA).
A long-awaited U.S. government study of the health effects of bisphenol A, a key building block of polycarbonate, seems to be giving the controversial chemical a clean bill of health in food packaging.
The largest-ever study on Bisphenol A (BPA) has confirmed that it is safe for consumers, says the US Food and Drug Administration (FDA), which conducted the multi-year research programme. European plastics manufacturers have welcomed the news. Speaking about the CLARITY-BPA core study, Dr Steven Ostroff, FDA Deputy Commissioner for Foods and Veterinary Medicine, said: “Our initial review supports our determination that currently authorised uses of BPA continue to be safe for consumers.” Jasmin Bird, spokesperson of the Polycarbonate/BPA-group of PlasticsEurope, added: “This largest ever study conducted on the topic indicates that BPA has very little potential to cause health effects even when people are exposed to it throughout their lives.”
Bisphenol A (BPA) has been the subject of global controversy in recent years, with some jurisdictions restricting its use in children’s products and baby bottles due to concerns about potential exposure risks. FDA’s longstanding position on BPA is that BPA is safe at the current levels occurring in foods. On February 23, 2018, the National Toxicology Program (NTP) released for public comment a pre-peer review draft report on the findings of a comprehensive two-year rodent study examining the potential effects of BPA on health. The study – conducted by senior scientists at the FDA’s National Center for Toxicological Research (NCTR) – is part of a collaborative effort called the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). CLARITY-BPA had two components: the core study conducted at NCTR according to FDA Good Laboratory Practice regulations and CLARITY-BPA academic studies of various health endpoints, conducted by grantees at academic institutions and using offspring of rodents derived from the core study…Dr. Stephen Ostroff, Deputy Commissioner for Foods and Veterinary Medicine at FDA, issued a statement highlighting the fact that the draft report points towards “minimal effects” and supports FDA’s longstanding position that BPA, at current levels occurring in food is safe.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.